Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/19/2020 10/20/2020 10/21/2020 10/22/2020 10/23/2020 Date
108.04(c) 108.36(c) 105.93(c) 109.48(c) 107.79(c) Last
4 228 515 3 873 504 5 716 007 4 954 280 3 395 508 Volume
-1.49% +0.30% -2.24% +3.35% -1.54% Change
More quotes
Financials (USD)
Sales 2020 33 885 M - -
Net income 2020 4 415 M - -
Net Debt 2020 11 438 M - -
P/E ratio 2020 44,7x
Yield 2020 1,32%
Sales 2021 38 229 M - -
Net income 2021 5 807 M - -
Net Debt 2021 8 390 M - -
P/E ratio 2021 34,8x
Yield 2021 1,45%
Capitalization 194 B 194 B -
EV / Sales 2020 6,06x
EV / Sales 2021 5,29x
Nbr of Employees 107 000
Free-Float 88,8%
More Financials
Company
Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the... 
More about the company
Notations Surperformance© of Abbott Laboratories
Trading Rating : Investor Rating :
More Ratings
All news about ABBOTT LABORATORIES
10:05aGLOBAL MARKETS LIVE : Intel, Mattel, Nordea…
10/22Quest raises profit forecast as COVID-19 tests demand to jump
RE
10/22ABBOTT LABORATORIES : Reports third-quarter 2020 results, achieves strong double..
AQ
10/21ABBOTT LABORATORIES : Raises 2020 Earnings Guidance
DJ
10/21ABBOTT LABORATORIES : 3Q Profit, Sales Rise on Covid-19 Testing
DJ
10/21Abbott says COVID-19 test demand to grow in 2021
RE
10/21ABBOTT : 3Q Earnings Snapshot
AQ
10/21ABBOTT LABORATORIES : Results of Operations and Financial Condition, Financial S..
AQ
10/21Abbott quarterly profit rises 28.3% on strong sales of COVID-19 tests
RE
10/21ABBOTT : Reports Third-Quarter 2020 Results; Achieves Strong Double-Digit Earnin..
PR
10/20ABBOTT LABORATORIES : - improved mental and physical condition is directly linke..
AQ
10/20CYBERTHEFT LAWSUIT : ERISA Fiduciary Breach Claims Dismissed Against Plan Sponso..
AQ
10/19ABBOTT LABORATORIES : Improved Mental and Physical Condition is Directly Linked ..
PR
10/16ABBOTT LABORATORIES : quaterly earnings release
10/15Roche diagnostics business surges as COVID-19 infections rise
RE
More news
News in other languages on ABBOTT LABORATORIES
03:05aLes résultats et les couvre-feux se ramassent à la pelle
02:02aEN DIRECT DES MARCHES : Air Liquide, Renault, Accor, Faurecia, Kering, Airbus, I..
10/22ABBOTT : bien orienté avec des propos de broker
10/22ABBOTT : Jefferies reste à 'achat', relève sa cible
10/21DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 21.10.2020 - 15.15 Uhr
More news
Analyst Recommendations on ABBOTT LABORATORIES
More recommendations
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 117,78 $
Last Close Price 109,48 $
Spread / Highest target 18,7%
Spread / Average Target 7,58%
Spread / Lowest Target -25,1%
EPS Revisions
Managers
NameTitle
Robert B. Ford President, CEO, Chief Operating Officer & Director
Miles D. White Executive Chairman
Robert E. Funck Chief Financial Officer & Executive Vice President
Roxanne Schuh Austin Independent Director
Samuel C. Scott Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ABBOTT LABORATORIES26.04%193 838
MEDTRONIC PLC-1.42%150 359
BECTON, DICKINSON AND COMPANY-11.35%69 884
HOYA CORPORATION15.74%43 234
BAXTER INTERNATIONAL INC.-2.60%41 233
DEXCOM, INC.80.94%37 894